Health Care & Life Sciences » Pharmaceuticals | Pharmesis International Ltd.

Pharmesis International Ltd. | Cash Flow

Fiscal year is January-December. All values SGD Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
196.00
946.30
685.80
904.40
262.70
1,246.30
Depreciation, Depletion & Amortization
715.70
545.90
385.50
322.10
285.20
286.10
Other Funds
158.60
233.20
707.90
172.10
22.70
235.30
Funds from Operations
1,070.20
167.20
1,779.20
410.20
45.10
1,297.10
Changes in Working Capital
711.80
1,955.30
555.80
6,119.00
502.10
498.80
Net Operating Cash Flow
358.40
1,788.10
2,334.90
6,529.20
547.20
798.30
Capital Expenditures
121.30
108.80
335.00
180.40
708.00
Sale of Fixed Assets & Businesses
-
40.90
-
-
-
Purchase/Sale of Investments
814.20
-
3,345.20
-
-
Net Investing Cash Flow
935.50
67.90
3,010.20
180.40
2,461.60
Issuance/Reduction of Debt, Net
-
1,028.10
2,188.10
-
-
Net Financing Cash Flow
-
1,028.10
3,588.30
-
-
Net Change in Cash
577.00
2,748.40
8,933.40
6,709.60
1,914.40
Free Cash Flow
237.10
1,679.30
1,999.90
6,709.60
160.80
Net Assets from Acquisitions
-
-
-
-
1,753.60
Change in Capital Stock
-
-
1,400.20
-
-

About Pharmesis International

View Profile
Address
No. 8 Yingbin Road
Chengdu Sichuan 611331
China
Employees -
Website http://www.pharmesis.com
Updated 07/08/2019
Pharmesis International Ltd. Is an investment holding company, which engages in the research, development, production, sale, and marketing of medicine and medicine formulated products for the treatment of illnesses relating to the liver and gall bladder. It operates through the following segments: Western Drugs, Traditional Chinese Medicine (TCM) Formulated Drugs, and Distribution. The Western Drugs segment involves in the chemically formulated drugs and is marketed under the Kinna brand.